Washington Trust Advisors »

Vertex Pharmaceuticals Incorporated shares owned by Washington Trust Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Washington Trust Advisors from 13F filings

Historical chart of Washington Trust Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Washington Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Washington Trust Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $219k 537 406.87
2023-09-30 $198k 570 348.00
2023-06-30 $203k 576 351.76
2023-03-31 $222k 704 315.07
2022-12-31 $188k 650 288.78
2022-09-30 $643k 2.2k 289.19
2022-06-30 $672k 2.4k 281.08
2022-03-31 $790k 3.0k 261.08
2021-12-31 $786k 3.6k 219.66

More positions owned by Washington Trust Advisors

Apple (AAPL)
Palo Alto Networks (PANW)
Quanta Services (PWR)
Visa Com Cl A (V)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Iqvia Holdings (IQV)
Booking Holdings (BKNG)
Meta Platforms Cl A (META)
Deere & Company (DE)
Alphabet Cap Stk Cl A (GOOGL)
Regeneron Pharmaceuticals (REGN)
Becton, Dickinson and (BDX)
ResMed (RMD)
Jacobs Engineering Group (J)

View all positions for Washington Trust Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated